Fusion Capital, LLC Amgen Inc Transaction History

Fusion Capital, LLC

$219 Million
Q2 2024

A detailed history of Fusion Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, Fusion Capital, LLC holds 22,937 shares of AMGN stock, worth $7.33 Million. This represents 3.27% of its overall portfolio holdings.

Number of Shares

22,937

Previous 23,289 1.51%

Holding current value

$7.33 Million

Previous $6.62 Million 8.23%

% of portfolio

3.27%

Previous 3.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$262.75 - $319.31 $92,488 - $112,397	-352 Reduced 1.51%	22,937 $7.17 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $159,171 - $192,139	592 Added 2.61%	23,289 $6.62 Million
Q4 2023 Jan 22, 2024	BUY	$255.7 - $288.46 $73,897 - $83,364	289 Added 1.29%	22,697 $6.54 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $345,685 - $429,178	1,581 Added 7.59%	22,408 $6.02 Million
Q2 2023 Aug 02, 2023	BUY	$214.27 - $253.37 $73,066 - $86,399	341 Added 1.66%	20,827 $4.62 Million
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $5,418 - $6,604	24 Added 0.12%	20,486 $4.95 Million
Q4 2022 Feb 10, 2023	BUY	$229.03 - $291.01 $78,786 - $100,107	344 Added 1.71%	20,462 $5.37 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $40,178 - $45,313	179 Added 0.9%	20,118 $4.54 Million
Q2 2022 Jul 13, 2022	BUY	$230.71 - $256.74 $133,119 - $148,138	577 Added 2.98%	19,939 $4.85 Million
Q1 2022 May 03, 2022	BUY	$219.27 - $242.57 $273,648 - $302,727	1,248 Added 6.89%	19,362 $4.68 Million
Q4 2021 Jan 12, 2022	BUY	$198.88 - $227.6 $515,894 - $590,394	2,594 Added 16.71%	18,114 $4.08 Million
Q3 2021 Nov 10, 2021	BUY	$212.27 - $248.7 $338,358 - $396,427	1,594 Added 11.45%	15,520 $3.3 Million
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $175,185 - $194,355	750 Added 5.69%	13,926 $3.39 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $147,348 - $171,710	664 Added 5.31%	13,176 $3.28 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $249,486 - $297,093	1,153 Added 10.15%	12,512 $2.88 Million
Q3 2020 Nov 06, 2020	SELL	$234.65 - $260.95 $11,028 - $12,264	-47 Reduced 0.41%	11,359 $2.89 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $50,243 - $61,655	254 Added 2.28%	11,406 $2.69 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $79,092 - $104,897	-434 Reduced 3.75%	11,152 $2.26 Million
Q4 2019 Feb 24, 2020	BUY	$189.21 - $243.2 $2.19 Million - $2.82 Million	11,586 New	11,586 $2.79 Million

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fusion Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fusion Capital, LLC with notifications on news.

Account

Fusion Capital, LLC Amgen Inc Transaction History